INTERPACE BIOSCIENCES, INC. Cash and Restricted Cash
INTERPACE BIOSCIENCES, INC. (IDXG) had Cash and Restricted Cash of $2.69 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.69M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.65M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.50M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.42M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $2.69M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.65M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.50M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.42M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $502.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $1.46M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $2.11M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $2.02M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $2.81M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $3.50M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $5.03M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $5.08M 10-K · filed 2025-03-31 | |
| 2023-03-31 | $5.60M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $4.83M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $6.31M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $2.12M 10-Q · filed 2023-08-09 | $2.10M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $3.31M 10-K · filed 2024-04-01 | $3.30M 10-K · filed 2022-03-31 |
| 2021-09-30 | $3.43M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $3.37M 10-K · filed 2023-03-27 |